논문 정보 : Kang, D. W., Shim, Y. B., Lee, E. K., & Park, M. H. (2022). Healthcare resource utilization and medical costs in patients with terminal cancer during best supportive care. PloS one, 17(6), e0269565.
논문 보기(doi) : 10.1371/journal.pone.0269565. eCollection 2022
논문 정보 : Jang, S. C., Kwon, S. H., Min, S., Jo, A. R., Lee, E. K., & Nam, J. H. Optimal indicator of death for using real-world cancer patients data from the healthcare system. Frontiers in Pharmacology, 1940.
논문 정보 : Ha SY, Kang DW, Jung HI, Lee EK, Park MH. Value-Based Pricing and Budget Impact Analysis for Multi-Indication Drugs: A Case Study of Immunotherapies. Int J Environ Res Public Health. 2022 Mar 30;19(7):4105.
논문 정보 : Yang SY, Kang DW, Nam JH, Choi EK, Lee EK, Shin JY, Kwon SH. Adherence is an optimal factor for maximizing the effective and safe use of oral anticoagulants in patients with atrial fibrillation. Sci Rep. 2022 Mar 1;12(1):3413.
논문정보 : Cho JY, Kwon SH, Lee EK, Lee JH, Kim HL. Cost-Effectiveness of Adjuvant Immunotherapy With Cytokine-Induced Killer Cell for Hepatocellular Carcinoma Based on a Randomized Controlled Trial and Real-World Data. Frontiers in Oncology. 2021 Dec 3;11:728740-.
논문정보 : Byun JY, Kim HL, Lee EK, Kwon SH. A Systematic Review of Economic Evaluations of Active Tuberculosis Treatments. Frontiers in Pharmacology.:3453.
논문정보 : Park H, Park CM, Woo J-M, Shin J-Y, Lee E-K, Kwon S-H. Real-world data analysis of the clinical and economic burden and risk factors in patients with major depressive disorder with an inadequate response to initial antidepressants. Journal of Medical Economics. 2021;24(1):589-97.
논문정보 : Koo BS, Lim YC, Lee MY, Jeon JY, Yoo HJ, Oh IS, et al. The risk factors and incidence of major infectious diseases in patients with ankylosing spondylitis receiving tumor necrosis factor inhibitors. Mod Rheumatol. 2021:1-14.
논문정보 : Kang HR, Jang SC, Shin JY. Association between oseltamivir use and neuropsychiatric adverse events in influenza patients: a nationwide population-based cohort study. Expert Opin Drug Saf. 2021;20(2):245-53.
논문정보 : Ha SY, Shim YB, Lee MY, Koo BS, Kim JH, Jeon JY, et al. Comparative Cost-Effectiveness of Tofacitinib With Continuing Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs for Active Rheumatoid Arthritis in South Korea. Rheumatol Ther. 2021;8(1):395-409.
논문 정보 : Kang, D. W., Shim, Y. B., Lee, E. K., & Park, M. H. (2022). Healthcare resource utilization and medical costs in patients with terminal cancer during best supportive care. PloS one, 17(6), e0269565.
논문 보기(doi) : 10.1371/journal.pone.0269565. eCollection 2022
논문 정보 : Jang, S. C., Kwon, S. H., Min, S., Jo, A. R., Lee, E. K., & Nam, J. H. Optimal indicator of death for using real-world cancer patients data from the healthcare system. Frontiers in Pharmacology, 1940.
논문 보기(doi) : 10.3389/fphar.2022.906211
논문 정보 : Ha SY, Kang DW, Jung HI, Lee EK, Park MH. Value-Based Pricing and Budget Impact Analysis for Multi-Indication Drugs: A Case Study of Immunotherapies. Int J Environ Res Public Health. 2022 Mar 30;19(7):4105.
논문 보기(doi) : 10.3390/ijerph19074105
논문 정보 : Yang SY, Kang DW, Nam JH, Choi EK, Lee EK, Shin JY, Kwon SH. Adherence is an optimal factor for maximizing the effective and safe use of oral anticoagulants in patients with atrial fibrillation. Sci Rep. 2022 Mar 1;12(1):3413.
논문 보기(doi) : 10.1038/s41598-022-07316-y
논문정보 : Cho JY, Kwon SH, Lee EK, Lee JH, Kim HL. Cost-Effectiveness of Adjuvant Immunotherapy With Cytokine-Induced Killer Cell for Hepatocellular Carcinoma Based on a Randomized Controlled Trial and Real-World Data. Frontiers in Oncology. 2021 Dec 3;11:728740-.
논문보기 : 10.3389/fonc.2021.728740
논문정보 : Byun JY, Kim HL, Lee EK, Kwon SH. A Systematic Review of Economic Evaluations of Active Tuberculosis Treatments. Frontiers in Pharmacology.:3453.
논문보기 : 10.3389/fphar.2021.736986
논문정보 : Park H, Park CM, Woo J-M, Shin J-Y, Lee E-K, Kwon S-H. Real-world data analysis of the clinical and economic burden and risk factors in patients with major depressive disorder with an inadequate response to initial antidepressants. Journal of Medical Economics. 2021;24(1):589-97.
논문보기 : 10.1080/13696998.2021.1918922
논문정보 : Koo BS, Lim YC, Lee MY, Jeon JY, Yoo HJ, Oh IS, et al. The risk factors and incidence of major infectious diseases in patients with ankylosing spondylitis receiving tumor necrosis factor inhibitors. Mod Rheumatol. 2021:1-14.
논문보기 : 10.1080/14397595.2021.1878985
논문정보 : Kang HR, Jang SC, Shin JY. Association between oseltamivir use and neuropsychiatric adverse events in influenza patients: a nationwide population-based cohort study. Expert Opin Drug Saf. 2021;20(2):245-53.
논문보기 : 10.1080/14740338.2021.1850690
논문정보 : Ha SY, Shim YB, Lee MY, Koo BS, Kim JH, Jeon JY, et al. Comparative Cost-Effectiveness of Tofacitinib With Continuing Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs for Active Rheumatoid Arthritis in South Korea. Rheumatol Ther. 2021;8(1):395-409.
논문보기 : 10.1007/s40744-021-00278-z